After 1 week of treatment, we observed lonafarnib (FTI) (1 μM) combined with everolimus (RAPA) (10 nM) restored the expression of DNA PKcs, Ku70, and Ku80 in progeria cell nuclei. Here, XRCC5 is linked to progeroid syndrome.